MoneyWorks4Me

Zydus Lifesciences - Quaterly Results

10 Aug 2022 Evaluate
The sales declined to Rs. 19809.00 millions for the June 2022 quarter as compared to Rs. 21234.00 millions during the corresponding quarter last year.Net profit declined -17.10% to Rs. 3315.00 millions from Rs. 3999.00 millions.The Operating Profit of the company witnessed a decrease to 5960.00 millions from 6473.00 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202206 202106 % Var 202206 202106 % Var 202203 202103 % Var
Sales 19809.00 21234.00 -6.71 19809.00 21234.00 -6.71 79819.00 77800.00 2.60
Other Income 517.00 297.00 74.07 517.00 297.00 74.07 1787.00 893.00 100.11
PBIDT 5960.00 6473.00 -7.93 5960.00 6473.00 -7.93 20968.00 23980.00 -12.56
Interest 406.00 442.00 -8.14 406.00 442.00 -8.14 1349.00 709.00 90.27
PBDT 5554.00 6031.00 -7.91 5554.00 6031.00 -7.91 16426.00 21396.00 -23.23
Depreciation 1231.00 1167.00 5.48 1231.00 1167.00 5.48 4787.00 4511.00 6.12
PBT 4323.00 4864.00 -11.12 4323.00 4864.00 -11.12 11639.00 16885.00 -31.07
TAX 1008.00 865.00 16.53 1008.00 865.00 16.53 3060.00 2123.00 44.14
Deferred Tax -6.00 15.00 -140.00 -6.00 15.00 -140.00 458.00 -910.00 -150.33
PAT 3315.00 3999.00 -17.10 3315.00 3999.00 -17.10 8579.00 14762.00 -41.88
Equity 1024.00 1024.00 0.00 1024.00 1024.00 0.00 1024.00 1024.00 0.00
PBIDTM(%) 30.09 30.48 -1.30 30.09 30.48 -1.30 26.27 30.82 -14.77
Peers
Company Name CMP
Sun Pharma. Inds. 1745.00
Dr. Reddys Labs. 1242.00
Cipla 1331.00
Lupin 1953.75
Zydus Lifesciences 1113.00
View more..